Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts Brent Oil Fd Lp Unit
BNO
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
US Stock MarketDetailed Quotes
NOVARTIS AG (NVSEF)
- 151.895
- 0.0000.00%
15min DelayClose Jul 16 14:25 ET
289.83BMarket Cap21.76P/E (TTM)
0.000High0.000Low38Volume0.000Open151.895Prev Close0.00Turnover0.00%Turnover Ratio21.24P/E (Static)1.91BShares167.29152wk High7.53P/B289.59BFloat Cap108.15552wk Low4.63Dividend TTM1.91BShs Float167.291Historical High3.04%Div Yield TTM0.00%Range %63.181Historical Low0.000Avg Price1Lot Size
NOVARTIS AG (NVSEF) News
Novartis Wins Full FDA Approval for Kidney Disease Drug Fabhalta in IgA Nephropathy
Novartis Gene Therapy Itvisma Approved in EU for Spinal Muscular Atrophy
Novartis and Antares to Develop Cancer Drugs in a Deal Worth up to $1.9B
Novartis Muscle Disease Therapy Succeeds in Early-stage Study
Kymera, Monte Rosa Among Gainers as Novartis Inks Deal for Molecular Glue Drugs
Novartis Misses Q1 Estimates; Reaffirms FY26 Guidance
Novartis Pulls Bid to Expand Pluvicto Label for Prostate Cancer in EU
Sanofi, Arrowhead, Novartis Among Winners of EU Recommendations This Week
WHO Prequalifies Novartis' Coartem Baby for Infants
NOVARTIS AG To Go Ex-Dividend On March 10th, 2026 With 3.80212 USD Dividend Per Share
March 8th (Eastern Time) - $NOVARTIS AG(NVSEF.US)$ is trading ex-dividend on March 10th, 2026.Shareholders of record on March 11th, 2026 will receive 3.80212 USD dividend per share on March 12th, 2026
Novartis Picks Texas to Build Next Radioligand Therapy Site
Novartis Inks Licensing Deal Worth up to $1.8B for Oral Peptide Drugs
Oakmark International Strategy Adds Unilever, Sanofi in Q4, Exits Novartis
6-K: Report of foreign private issuer (related to financial reporting)
20-F: FY2025 Annual Report
Novartis Wins FDA Breakthrough Status for Sjögren's Disease Therapy
Teva Seeks Removal of Over 200 Patents From FDA Orange Book After FTC Challenge
Roche Boosts Olema After Additional Late-stage Trial Data for Breast Cancer Drug
Roche Boosts Olema as Breast Cancer Therapy Succeeds in Late-stage Trial
Novartis Says Novel Antimalarial Succeeded in Late-stage Trial
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On Thursday, July 16 local time, U.S. forces launched another round of airstrikes against Iran for the fifth consecutive night. Iran warned
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm